TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership505,650 shares
Latest Disclosed Value $ 16,797,692
UBS Group AG ownership in 1TGTX / TG Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 505,650 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $13,986,279 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 537,019 shares of TG Therapeutics, Inc.. This represents a change in shares of -5.84% during the quarter. The current value of the position is $17,192,100 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (1TGTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 6,300 of underlying shares valued at $209,286 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TGTX / TG Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 505,650 -31,369 -5.84 16,798 4.93 0.0005
2026-01-29 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 537,019 -81,209 -13.14 16,009 -28.32 0.0026
2025-11-13 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 618,228 86,787 16.33 22,333 16.77 0.0035
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 531,441 -100,250 -15.87 19,127 -23.21 0.0033
2025-05-13 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 631,691 -15,406 -2.38 24,908 27.88 0.0046
2025-02-14 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 647,097 -18,858 -2.83 19,478 25.04 0.0036
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 665,955 145,723 28.01 15,577 68.32 0.0034
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 520,232 -4,390 -0.84 9,255 15.98 0.0023
2024-05-13 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 524,622 -40,214 -7.12 7,980 -17.29 0.0020
2024-02-09 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 564,836 209,271 58.86 9,647 224.60 0.0029
2023-11-09 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 355,565 210,173 144.56 2,973 -17.70 0.0010
2023-08-11 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 145,392 -121,488 -45.52 3,612 -10.02 0.0012
2023-05-12 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 266,880 -188,887 -41.44 4,014 -25.56 0.0015
2023-02-08 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 455,767 433,782 1,973.08 5,392 4,015.27 0.0020
2022-11-10 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 21,985 -113,366 -83.76 131 -77.26 0.0001
2022-08-10 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 135,351 -18,572 -12.07 576 -60.66 0.0002
2022-05-16 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 153,923 -99,869 -39.35 1,464 -69.64 0.0005
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 253,792 172,501 212.20 4,822 78.26 0.0014
2021-11-15 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 81,291 74,994 1,190.95 2,705 1,008.61 0.0009
2021-08-13 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 6,297 -41,303 -86.77 244 -89.37 0.0001
2021-05-12 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 47,600 39,630 497.24 2,295 453.01 0.0008
2021-02-11 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 7,970 -579 -6.77 415 81.22 0.0001
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 8,549 2,122 33.02 229 83.20 0.0001
2020-07-31 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 6,427 -61,456 -90.53 125 -81.29 0.0001
2020-05-01 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 67,883 33,383 96.76 668 74.41 0.0003
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 34,500 -240,699 -87.46 383 -75.21 0.0001
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 275,199 59,606 27.65 1,545 -17.16 0.0006
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 215,593 190,407 756.00 1,865 818.72 0.0007
2019-05-14 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 25,186 -339,197 -93.09 203 -86.41 0.0001
2019-02-14 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 364,383 323,887 799.80 1,494 561.06 0.0007
2018-11-14 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 40,496 3,559 9.64 226 -53.50 0.0001
2018-08-14 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 36,937 -166,923 -81.88 486 -83.21 0.0002
2018-05-15 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 203,860 128,766 171.47 2,895 369.97 0.0012
2018-02-14 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 75,094 -40,365 -34.96 616 -54.97 0.0003
2017-11-14 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 115,459 96,960 524.14 1,368 635.48 0.0006
2017-11-14 2017-06-30 13F/A-1 TG THERAPEUTICS COM 88322Q108 18,499 3,893 26.65 186 8.77 0.0001
2017-08-14 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 18,499 3,893 186
2017-11-14 2017-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 14,606 3,736 34.37 171 242.00 0.0001
2017-05-12 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 14,606 3,736 171
2017-02-14 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 10,870 3,873 55.35 50 -7.41 0.0000
2016-11-14 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 6,997 -793 -10.18 54 12.50 0.0000
2016-08-12 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 7,790 -4,114 -34.56 48 -52.48 0.0000
2016-05-12 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 11,904 -63,280 -84.17 101 -88.74 0.0001
2016-02-16 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 75,184 57,113 316.05 897 392.86 0.0006
2015-11-13 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 18,071 11,471 173.80 182 65.45 0.0001
2015-08-14 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 6,600 -500 -7.04 110 0.00 0.0001
2015-05-14 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 7,100 -1,385 -16.32 110 -18.52 0.0001
2015-02-17 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 8,485 8,485 135 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-13 2025-09-30 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Call 144,400 5,197 n/a n/a n/a
2015-05-14 2015-03-31 13F TG THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F TG THERAPEUTICS COM Call 100 2 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F TG THERAPEUTICS COM Put 6,300 -1.56 209 10.00 n/a n/a n/a
2026-01-29 2025-12-31 13F TG THERAPEUTICS COM Put 6,400 -20.00 191 -34.26 n/a n/a n/a
2025-11-13 2025-09-30 13F TG THERAPEUTICS COM Put 8,000 0.00 289 0.70 n/a n/a n/a
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM Put 8,000 288 n/a n/a n/a
2024-02-09 2023-12-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-09 2023-09-30 13F TG THERAPEUTICS COM Put 17,700 -51.77 148 -83.86 n/a n/a n/a
2023-08-11 2023-06-30 13F TG THERAPEUTICS COM Put 36,700 912 n/a n/a n/a
2020-05-01 2020-03-31 13F TG THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TG THERAPEUTICS COM Put 1,000 11 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.